Urology Doctors in Coconut Creek, FL Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Dr. Marvin L Stein, MD Urology Medicare: Medicare Enrolled Practice Location: 4515 Wiles Rd Ste 201, Coconut Creek, FL 33073 Phone: 954-943-1133    Fax: 954-783-6845

Sanjeev K Gupta, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4515 Wiles Rd Ste 201, Coconut Creek, FL 33073 Phone: 954-943-1133    Fax: 954-783-6845

Dr. Kenneth L. Janson, M.D. Urology Medicare: Medicare Enrolled Practice Location: 4443 Lyons Rd Ste 211, Coconut Creek, FL 33073 Phone: 954-405-0501    Fax: 954-301-8501

Darren Jeremy Bryk, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4515 Wiles Rd Ste 201, Coconut Creek, FL 33073 Phone: 954-943-1133    Fax: 954-783-6845

Dr. Christopher Thomas Tallman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4515 Wiles Rd Ste 201, Coconut Creek, FL 33073 Phone: 954-943-1133    Fax: 954-783-6845

News Archive

Biomagnetics Diagnostics obtains handheld IOBS unit to detect pathogens

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received its first handheld integrated optical biosensor unit from Los Alamos National Security, LLC.

Nutrient-rich powder from wine by-products

Two years ago, a group of friends were enjoying a glass of wine in the Mosel region in south-west Germany when their conversation turned to the health benefits which studies attribute to the drink.

Olfactory impairment linked with milder clinical course in COVID-19

Following an earlier study that validated the loss of smell and taste as indicators of SARS-CoV-2 infection, researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.

Combination therapy delays progression for metastatic breast cancer patients

Phase III trial results show that a combination of the aromatase inhibitor anastrozole and fulvestrant, an analog of estradiol that downgrades the estrogen receptor, is superior to anastrozole alone in prolonging progression-free survival in patients with metastatic breast cancer.

Read more Medical News

› Verified 8 days ago